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ABSTRACT Wehaveusedaquartz crystalmicrobalancewith dissipation (QCM-D) tomonitor the changes in layer thickness and
viscoelastic properties accompanying multilayer amyloid deposition in situ for the ﬁrst time. By means of atomic force microscope
imaging, an unequivocal correlation is established between the interfacial nucleation and growth of glucagon ﬁbrils and theQCM-D
response. The combination of the two techniques allows us to study the temporal evolution of the interfacial ﬁbrillation process.We
have modeled the QCM-D data using an extension to the Kelvin-Voigt viscoelastic model. Three phases were observed in the
ﬁbrillation process: 1), a rigid multilayer of glucagon monomers forms and slowly rearranges; 2), this multilayer subsequently
evolves into a dramatically more viscoelastic layer, containing a polymorphic network of micrometer-long ﬁbrils growing from
multiple nucleation sites; and 3), the ﬁbrillar formation effectively stops as a result of the depletion of bulk-phase monomers,
although the process can be continued without a lag phase by subsequent addition of fresh monomers. The robustness of the
QCM-D technique, consolidated by complementary atomic forcemicroscope studies, shouldmake it possible to combine different
components thought to be involved in the plaque formation process and thus build up realistic models of amyloid plaque formation
in vitro.
INTRODUCTION
The ability of certain polypeptides to aggregate into long, thin
needle-shaped amyloid structures and their subsequent
deposition at plaque sites in different parts of the body is
associated with multiple protein-folding disorders (1,2). For
instance, a stretch of polyglutamine that repeats in a particular
protein has been proposed as the cause of many neurological
disorders, including Huntington’s disease and spinal bulbar
muscular atrophy, and aggregation of other unrelated proteins
is correlatedwith prion disease (PrP aggregation), Alzheimer’s
disease (Ab-peptide), Parkinson’s disease and amyotrophic
lateral sclerosis (ALS) (a-synuclein aggregation), dialysis-
related amyloidosis (b-2 microglobulin aggregation), corneal
dystrophy (keratoepithelial deposits), and aggregation of islet
amyloid polypeptide in .95% of type II diabetes (3).
Although the cytotoxic species in the aggregation process
has been proposed to be an early preﬁbrillar oligomer with
enhanced cell membrane-permeabilizing properties (4), a
detailed understanding of the temporal sequence of events
leading up to the nucleation and growth of these ﬁbrillar de-
posits is important for the development of therapeutic strat-
egies. Fibrillar deposits also serve a useful purpose in their
own right for the formation of bacterial bioﬁlm (5), fungal
spore production (6), and melansome production in the skin
(7), making those interesting biotechnological role models.
Here we investigate the dynamic ﬁbrillation of glucagon,
a 29-amino acid peptide amphiphatic hormone connected to
the regulation of blood glucose levels and used therapeuti-
cally in the treatment of severe hypoglycemia (8). Glucagon
has a strong propensity to aggregate under a variety of buffer
conditions (pH, temperature, agitation, and salts) (9–11),
which limits the stability of the hormone. The ensuing ﬁbrils
differ signiﬁcantly in secondary structure, suggesting an in-
herent structural plasticity of the hormone, which may also
be reﬂected at the level of the actual ﬁbrils (9–11).
The multifaceted hierarchy of glucagon ﬁbrillogenesis
was recently mapped using atomic force microscopy (AFM)
by ex situ observing the products of the ﬁbrillation process
formed freely in the bulk under acidic conditions and sub-
sequently immobilized on surfaces (12,13). Because in vivo
conditions associated with amyloid ﬁbrillation, however,
are often dictated by surface and lipid membrane phenom-
ena (1,3), the in situ temporal study of amyloid ﬁbrillation at
the solid-liquid interface represents an important and
physiologically relevant approach to the study of amyloid
ﬁbrillogenesis. This relevance is emphasized by the differ-
ences found in ﬁbril morphology in various polypeptide
systems depending both on bulk or surface assembly and on
the physiochemical properties of the conﬁning interface
(14–17).
In situ AFM imaging has revealed unique insight into the
initial monomer adsorption and organization of the amyloid-
peptide Ab, depending on a hydrophilic versus hydrophobic
surface assembly (14), and in the study of insulin ﬁbrillation
on model lipid-water interfaces, the ﬁbril morphology was
reported to depend on bulk or surface assembly but also on
the electrostatic nature of the lipids (15). Assembly of amylin
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on mica was likewise found to differ signiﬁcantly from that
grown in the bulk (16), and in one case, by studying the
ﬁbrillation of the light chain domain SMA on different
functionalized surfaces (negative charged, positive charged,
or hydrophobic) (17), it was shown that the surface chem-
istry and buffer conditions had a strong inﬂuence on the ﬁbril
formation on negatively charged mica. Furthermore, it was
suggested that a secondary surface-induced assembly path-
way existed with elongation and accelerated growth from
multiple nucleation points (17).
Despite the wealth of structural detail provided at the level
of individual ﬁlaments by these pioneering AFM studies, it is
important to elucidate at a more general level how the surface
is colonized by the growing mass of amyloid. The ultimate
goal is to allow us to model amyloid plaque formation in
vitro. Structural and mechanistic details of its undoubtedly
complex formation in vivo remain elusive, but we hope that a
realistic reconstruction of the plaque’s characteristic me-
chanical and viscoelastic properties will provide a better un-
derstanding of the processes controlling its biological genesis,
particularly the contributions made by components such as
heparin and apolipoprotein E4 to the buildup and consoli-
dation of the protein deposit. In the long term, this may in-
spire future therapeutic strategies.
Here we report on the use of a quartz crystal microbalance
with dissipation (QCM-D) to follow the dynamic process of
glucagon ﬁbrillation at the solid-liquid interface in situ.
QCM-D allows us to follow the coupling between initial
deposition and structural rearrangements leading to growth
in layer thickness and accompanying changes in the de-
posited layer’s viscoelastic properties. We reveal that a clear
correlation can be established between the QCM-D response
and the dynamic ﬁbrillation process by comparing the
temporal QCM-D response to time-lapsed AFM images of
the ﬁbrillation. Further, we modeled the experimental results
using an extended viscoelastic model, which allowed us to
obtain detailed time-resolved insight into the dynamic inter-
facial response during the ﬁbrillogenesis process.
MATERIALS AND METHODS
Glucagon and ﬁlm preparation
Pharmaceutical grade glucagon protein powder (Novo Nordisk A/S,
Bagsværd, Denmark, purity .98.9%) was dissolved to a concentration of
2.5 mg/ml at pH 2.0 (10 mMHCl and 1 mMNa2SO4) and initially incubated
at 23C for 5 min, with great care taken to ensure reproducible mixing
conditions during the procedure. This procedure involved using a micro-
pipette to gently aspirate the samples at 23C a ﬁxed number of times during
mixing and making sure not to introduce air bubbles in the procedure.
Standard 5-MHz AT-cut gold-coated quartz crystals (QSense AB,
Gothenberg, Sweden) were coated with 500 A˚ of tantalum (Ta) by e-gun
evaporation. From x-ray photoelectron spectroscopy (XPS) results, we can
conclude that the exposure of the Ta ﬁlms to ambient conditions led to the
formation of a 20–50 A˚ thick top layer of native tantalum oxide (Ta2O5). All
ﬁlms were UV/ozone (UVO) pretreated for 40 min to ensure a clean,
hydrophilic surface.
Quartz crystal microbalance with dissipation
QCM-D experiments were performed in parallel duplicates using two axial
ﬂow chambers, QAFC 301 and QAFC 302, from Q-Sense AB. The QCM-D
technique (18) has proven to be well suited for in situ dynamic monitoring of
both mass and mechanical properties, such as viscoelasticity of absorbed
biomolecules (19,20). The AT-cut quartz crystal is piezoelectric and deforms
mechanically when exposed to an electrical ﬁeld. By applying a radio
frequency (RF) ac voltage across the crystal, a shear oscillation is induced at
the resonance frequency or at overtones 3, 5, and 7; for the crystals used here,
the ground resonance frequency is 4.95 MHz. Information about the
adsorption process is obtained by the simultaneous measurement of changes
in the resonance frequency (DFN) and the dissipation factor (DDN) at each
Nth overtone. The shift in dissipation onDDN provides information about the
viscoelastic properties of the adsorbed layer. For rigid ﬁlms displaying little
shift in dissipation (DDN,;8–103 10
6), the change in the Nth overtone
resonance frequency,DFN, is proportional to the change in the total adsorbed
surface mass density (G) via the Sauerbrey equation (21,22):
DFN ¼ N 2F
2
1
ðr0m0Þ1=2
G: (1)
The quantities of r0 and m0 are the density and shear modulus of quartz,
respectively, whereas F1 is the baseline fundamental resonance frequency.
For increasing viscoelastic layers, the more advanced Kelvin-Voigt
formalism is often employed (23–25). This model relates the observed shift
in frequency (DF) and dissipation (DD) to the thickness and viscoelastic
properties (shear modulus and shear viscosity) of the forming layer. All
experiments were performed at a controlled temperature of 22.9 6 0.1C.
Samples were injected into the two chambers after a stable baseline buffer
signal (drift ,0.1 Hz/min on the third overtone) and an initial thermal
equilibration of the sample. At least ﬁve experiments were performed for
each condition, i.e., each result reported (mean 6 SD).
Atomic force microscopy
AFM is particularly useful for studying ﬁbrillar ultrastructure, as it permits
visualization of individual biological macromolecules at the nanometer scale
(26–28). To conduct parallel AFM and QCM-D studies, several Ta-coated
quartz crystals were incubated in individual small tubes simultaneously with
the injection of freshly prepared glucagon solution into the QCM-D
chamber. At each point of interest, a sample was removed from the
incubation tubes and imaged using a commercial Nanoscope IIIa MultiMode
AFM (Veeco Instruments, Santa Barbara, CA) under ambient conditions at
23C. To quantitatively check for any inﬂuence originating from the
differences in experimental conditions between the QCM-D experiments
and the incubated samples, all AFM results were additionally repeated by
interrupting the QCM-D experiment at certain time sequences and imaging
these QCM surfaces directly by AFM. Overall, very good agreement was
obtained, implying that the AFM images presented are representative for the
temporal evolution corresponding to the QCM-D results. AFM imaging was
performed in the tapping mode at scan frequencies of 1–2 Hz with minimal
loading forces applied and by optimized feedback parameters. These
conditions ensured that any sample distortion by tip compression is reduced
to an absolute minimum. Silicon nitride cantilevers (NSG01, NT-MDT,
Russia) were used with a typical resonance frequency of 150 kHz, a spring
constant of 5.5 N/m, and a typical tip radius of 10 nm. The AFM images
were obtained by recording 512 3 512 pixels, and several images were
always obtained from separate locations across the Ta-coated crystals at each
time point of interest to ensure that data presented are representative of
actual surface morphology. All AFM images were globally ﬂattened and
visualized using the commercial Scanning Probe Image Processor software
(SPIP, Image Metrology ApS, Version 4.2, Lyngby, Denmark).
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RESULTS AND DISCUSSION
Time-resolved QCM-D data are depicted in Fig. 1 a, where
the QCM-D frequency shift DF and the dissipation response,
DD of overtone 7 are displayed as a function of glucagon
exposure time. Because of the extended period of observa-
tion, additional control experiments on a similar timescale
were performed with buffer only injected, in which case no
dynamic DF or DD signals were observed (data not shown).
The QCM-D glucagon response can be tentatively divided
into three characteristic regions referred to as I, II, and III,
respectively, in Fig. 1 a. First, after the injection of glucagon,
a DF decrease is observed as the adsorption of monomers
forms an initially rigid layer as concluded from the small
increase in DD (,5 3 106) (Fig. 1 a, section I). Both the
frequency shift DF and dissipation shift DD display a
behavior corresponding to typical adsorption phenomena
(21,23). This observation is further conﬁrmed by the cor-
responding AFM images (see Fig. 1 c) of the adsorbed layer
of biomolecules after the initial fast adsorption (;200 min).
A signiﬁcant aggregation of particle-like structures is ob-
served, forming a complete homogeneous layer of globular
structures across the Ta surface. Similar rigid layer formation
has been observed using QCM-D in case of Ab(1–40) mono-
mer adsorption on various substrates (29) but without mon-
itoring the subsequent ﬁbrillation.
After a characteristic lag time of 430 6 97 min, the
adsorbed layer is observed to transform dramatically, be-
coming notably more viscoelastic as reﬂected by the signiﬁ-
cant increase in the dissipation DD and frequency DF (see
Fig. 1, section II). This behavior is ascribed to a result of
glucagon ﬁbrillation at the Ta surface, as ﬁbrils start to appear
in the AFM images (see Fig. 1 d, indicated by the arrow) as
opposed to the previous nonstructured aggregates in the AFM
images (Fig. 1 c). A similar ﬁbrillation lag period is also ob-
served in other studies using spectroscopic techniques, such as
binding of the ﬂuorescent probe thioﬂavin T, tryptophan ﬂuo-
rescence, or changes in the far-UV CD signal (9,10).
The dynamic process of ﬁbrillation continuously trans-
forms the interfacial glucagon layer throughout this phase, as
depicted from subsequent time points in Fig. 1, e and f.
Distinct micrometer-long ﬁbrils are clearly visible, forming
locally an increasingly dense and viscoelastic network of
ﬁbrils. This observation is in good agreement with earlier
AFM studies (12,13) where glucagon ﬁbrillation takes place
after a characteristic lag period, resulting in an increasingly
elaborate network of ﬁbril species.
At this stage it was not clear whether the observed
increases in DF and DD were caused by a rapid adsorption or
formation of various mature and viscoelastic ﬁbrillar species
in the bulk solution or if they were truly a surface phe-
nomenon. To test this, a ﬂushing procedure was performed at
different time points. If the observed increases in frequency
and dissipation were effects of the change in bulk solution
properties only (viscosity and density), the process should be
completely reversible by ﬂushing with buffer solution. This,
however, is not the case. When the chamber is ﬂushed with
buffer midway in the experimental time cycle (Fig. 2 b) or at
the end of an experiment (Fig. 2 c), there is a slow desorption
curve with a plateau value higher than that seen at the start of
the experiment. In addition, if ﬂushing is performed directly
FIGURE 1 Representative QCM-D and AFM data from a typical experiment, displaying the observed frequency (DF7) and dissipation (DD7) shifts for
overtone 7 (a) along with the combined time-independent DD7 versus DF7 graphs (b). At important time points, marking transitions of the observed QCM-D
signal (arrows 1 and 2 in a and b), corresponding AFM images are displayed (c–e) along with an end-of-experiment image from 1700 min when no further
dynamics is observable (QCM-D data displayed only until 1500 min).
2164 Hovgaard et al.
Biophysical Journal 93(6) 2162–2169
after the formation of the initial rigid layer (Fig. 2 a), we still
observe the characteristic dynamics of the ﬁbrillation and, in
particular, a similar lag time. In all three ﬂushing experi-
ments, the presence of ﬁbrils was conﬁrmed by direct im-
aging by AFM. On the basis of these observations, we thus
conclude that the observed onset of ﬁbrillation is caused by
a slow dynamic reconﬁguration within the already formed
interfacial glucagon layer.
However, during the process, the ﬁbrillation process is not
independent ofmass transfer from the bulk glucagon solution.
Exchange with buffer solution shortly after the initial
deposition extends the process time by a factor of ;2 once
the ﬁbrillation has been initiated (Fig. 2 a; notice the longer
timescale). Furthermore, the ﬁbrillation process on the crystal
can be stopped at a given time point, as seen from Fig. 2, b and
c. The ﬁnal QCM-D response to the ﬁbrillation (Fig. 1 a,
section III) shows that the limited availability of monomers in
the bulk solution ultimately terminates the growth of ﬁbrils
and slowly guides the process into a stable regime with no
further dynamic rearrangement of the glucagon observable.
This depletion behavior is also evident from the time-in-
dependent dissipation DD versus frequency DF plots (Fig.
1 b), where the ﬁnal transition between sections II and III
(indicated by arrow 2 in Fig. 1 b) does not alter the slope of the
DD-DF curve, which conﬁrms that the process results from
depletion rather than a conﬁguration change. Interestingly,
theDD-DF plot provides an unambiguous identiﬁcation of the
transition from phase I to phase II (indicated by arrow 1 in
Fig. 1 b), giving a unique ﬁngerprint of the onset of ﬁbrillation
and the subsequent growth process. Furthermore, although
multiple ﬁbrils are found across the entire crystal interface at
this ﬁnal phase III of the experiment, a large number of dense
macroscopic (.100mm) ﬁbril islands coexist, as displayed in
Fig. 3. This coexistence strongly suggests that the ﬁbrillation
process is governed by interfacial nucleation sites, as also seen
for Ab(1–40) amyloids (29).
To obtain further microscopic insight into the dynamic
interfacial ﬁbrillation process, we have applied a simple
model of the QCM-D frequency and dissipation response.
In the initial phase (Fig. 1, section I), a linear scaling of
overtones 3, 5, and 7 of DF is always observed along with
a low dissipation DD value (,5 3 106). This observation
implies that the change in resonance frequency, DFN of the
Nth overtone, can be related to the change in the adsorbed
surface mass density G via the Sauerbrey equation (Eq. 1).
A representative curve of the modeled surface mass den-
sity is displayed in Fig. 4. On average, G saturates at 420 6
42 ng/cm2. In the approximation of a closely packed side-
by-side orientation of extended glucagon monomers in a
b-sheet conﬁguration of dimensions 101.5 A˚ 3 10 A˚ (cor-
responding to a monomer area of 1.01 3 1013 cm2, i.e.,
;55 ng/cm2), this is equal to a lower limit of ;7 adsorbed
monolayers.
However, because the QCM-D technique measures the
complete hydrated mass of the adsorbed biomolecules, the
actual number of glucagon molecules on the surface will be
signiﬁcantly smaller (21). Because glucagon monomers are
expected to adsorb randomly and not in a well-ordered
b-packing across the entire interface, the observed surface
mass density still suggests multilayer formation. This
FIGURE 2 Observed QCM-D response to buffer ﬂushing (arrows 1–3)
after the initial rigid layer formation (a), midway during the dynamic
ﬁbrillation (b), and at the end of an experiment (c). Notice the similar time-
scales of b and c in contrast to the approximately twice as long scale in a.
FIGURE 3 Optical image of a locally dense ﬁbril island present on the
tantalum surface in the ﬁnal phase III of the dynamic process. The presence
of multiple islands suggests a ﬁbrillation potentially governed by interfacial
nucleation sites.
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suggestion is in correspondence with the AFM data dis-
played in Fig. 1 a, which reveals a strong aggregation of
particle-like structures.
To further describe the continued ﬁbrillation process
through phases II and III, we went beyond the simple Sauerbrey
model and instead used the more advanced Kelvin-Voigt
model (23–25) for the QCM-D data analysis. This applica-
tion was motivated by the extreme viscoelastic behavior
monitored by QCM-D of the rather complex network of
ﬁbrils, causing the Sauerbrey model to fail from the onset of
ﬁbrillation. As displayed in Fig. 4, the surface mass density
shows an inconsistent overtone dependence (cf. Eq. 1) and a
marked reduction of the surface mass density, reﬂecting the
increase in frequency in phases II and III. This apparent
reduction in density is clearly at odds with the ﬁbril growth
observed by AFM, where there is an accumulation of ma-
terial on the surface. To clarify this paradox, we introduced
an expansion of the original Kelvin-Voigt model and include
a linear frequency dependence of the shear viscosity (h) and
shear modulus (m) for the multilayers formed, as described
by Eqs. 2 and 3. This introduction turned out to be a neces-
sary and sufﬁcient step to obtain a satisfactory correspon-
dence with measured data. In the model, positive coupling
constants (a, b) imply that the shear viscosity and shear
modulus increase with frequency. Simultaneous ﬁtting of
frequency overtones 5 and 7 along with dissipation are done
pointwise using a least-squares algorithm, varying the thick-
ness (h1), shear viscosity, and the shear modulus of the
adsorbed layer. These parameters are subsequently recom-
bined to yield the surface mass density G (h1r1) along with
the ﬁtted viscoelastic parameters.
DFN ¼ 1
2pr0h0
h1r1vN 
h2
d2;N
 2
2h1h1;Nv
2
N
m
2
1;N1 ðvNh1;NÞ2
 !
DDN ¼ 2
r0h0vN
h2
d2;N
 2
2h1h1;NvN
m
2
1;N1 ðvNh1;NÞ2
 !
(2)
m1;N ¼ m1;1 3 ð11 ðN  1Þ3aÞ
h1;N ¼ h1;1 3 ð11 ðN  1Þ3bÞ: (3)
This extended three-layer viscoelastic model displays the
relationship between the observed Nth overtone frequency
(DFN) and dissipation shift (DDN) and the viscoelastic pa-
rameters of the forming layer (annotated 1), the extending
bulk (annotated 2), and the oscillating crystal (annotated 0).
The free model parameters are the shear viscosity (h1,N), the
thickness (h1), and the shear modulus (m1,N) of the adsorbed
overlayer for the Nth overtone. The linear dependence of
the shear modulus (m1,N) and the shear viscosity (h1,N) are
expressed via the coupling constants a,b. For further details
concerning Eq. 2, see Voinova et al. (24).
To determine the optimal linear coupling constants (a,b)
of the overtone dependence of m and h (Eq. 3), a grid search
x2 analysis was performed, ﬁtting data according to Eq. 2
while at each ﬁt keeping the couplings (a,b) at ﬁxed grid
values for the entire data set. Note that the optimized cou-
pling constants often have a large variance depending on the
actual data, with large constants (;0.5) usually correspond-
ing to smaller values of the ﬁnal surface density and weak
couplings (;0.01) conversely to large values. In all cases,
the couplings corresponding to the minimal x2 values were
used as ﬁnal model parameters, as illustrated in Fig. 5. The
residuals, between the modeled values and the measured
frequency and dissipation response, were always ,0.9 Hz
and 0.1 3 106 for DF and DD, respectively.
Representative curves for the temporal development of the
viscoelastic parameters h and m are displayed for the
fundamental frequency (N ¼ 1) in Fig. 6. Both the shear
viscosity and the shear modulus decrease as the ﬁbrils
evolve, reaching values of 3.5 6 0.85 3 104 Pas and 7 6
1.3 3 105 Pa, respectively. The noise present in the early
stages of the process is caused by the initially low dissipation
values, which make modeling according to Eqs. 2 and 3 and
FIGURE 4 Representative modeling results for the surface mass density
(G) according to the Sauerbrey model, for overtones 3, 5, and 7 simul-
taneously. The model successfully applies for the initial, rigid multilayer
formation, showing little overtone dependence. At ;750 min, however, the
system displays a increasing viscoelastic behavior, making the interpretation
within the Sauerbrey model invalid (after arrow).
FIGURE 5 Three-dimensional plot of x2 grid analysis for a representative
experiment in the vicinity of minimum. In this particular case, as indicated
by the cross, the optimized couplings a and b were 0.8010 and 0.1501,
respectively.
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a determination of the viscoelastic properties difﬁcult. From
the modeled curves of surface mass density (Fig. 7), one
should notice the initial positive correspondence in phase I
between the simple Sauerbrey equation and the extended
model. It is evident that the continued ﬁbrillation beyond the
characteristic lag time gives rise to a signiﬁcant increase in
surface mass densities G. This increase marks the onset of
growth in the vertical (stacking) or horizontal (more dense
surface packing) direction, possibly combined with a change
in layer hydration.
Because of the nature of theKelvin-Voigtmodel employed,
these modeled parameters can only be interpreted as mean
values across the crystal surface. Quantitatively, however,
they are in excellent agreement with the observed scenario
(Fig. 1, c and d) of monomers or oligomers slowly being
excluded from the layer as the ﬁbrils mature. This process
gradually forms a dense network with micrometer-long
ﬁbrils, continuously growing from multiple nucleation sites.
In turn, the layer becomes notably more viscoelastic, with
both the density and the height increasing locally as well as
globally. In the ﬁnal phase III of the process, the viscoelastic
parameters and the modeled surface mass density level off
(Figs. 6 and 7), as the ﬁbrillation process halts because of the
depletion of nonﬁbrillated glucagon material. In regard to the
surface mass density, notice the intuitively correct modeled
behavior after ﬂushing with buffer, with a subsequent slow
decrease in G (Fig. 7). This behavior is in contrast to the DF
data (Fig. 2 c), showing a decrease in frequency, which
usually signiﬁes a mass increase within the simple Sauerbrey
model. This correspondence clearly demonstrates the appli-
cability of the extended viscoelastic model introduced here.
Having successfully identiﬁed and modeled the visco-
elastic development of a single glucagon injection, we ad-
ditionally investigated whether this process of interfacial
ﬁbrillation could be continued by a secondary injection. As
presented in Fig. 8, the introduction of a freshly prepared
glucagon monomer solution led to a large, but slow increase
in dissipation. On the basis of the slow kinetics displayed and
the magnitude of the dissipation shift, we interpret this as a
direct continuation of the ﬁbrillation process, but interest-
ingly with no secondary lag period needed. This ﬁnding is
additionally supported by the modeled surface mass density,
showing a signiﬁcant increase resembling the onset of the
initial ﬁbrillation.
CONCLUSION
In this study, we have successfully applied the QCM-D in
combination with parallel AFM imaging to study glucagon
ﬁbrillation at the solid-liquid interface. A clear correspon-
dence between the process of interfacial ﬁbrillation and the
QCM-D response has been established. From the experi-
mentally observed changes in frequency DF and dissipation
DD, three phases in the dynamic ﬁbrillation were identiﬁed,
which were additionally evident in the corresponding
FIGURE 6 Temporal development of the parameterized viscoelastic pro-
perties of the ﬁbrillating layer. Both the shear viscosity and shear modulus
decrease as the ﬁbrillation evolves.
FIGURE 7 Modeled surface mass density (G) according to the extended
viscoelastic Kelvin-Voigt model, throughout the three characteristic regimes
observed (I, II, and III) for a representative experiment, along with an
illustration of dynamic interfacial ﬁbrillation. Note the intuitively correct
behavior modeled at the end-of-experiment ﬂushing (arrow), showing a
characteristic desorption behavior.
FIGURE 8 Reinjection of glucagon monomers (arrow 2) leads to a
dramatic but slow incense in DD and G. Because of the amplitude and
kinetics of the response, as compared with the initial injection of monomers
(arrow 1), this indicates a direct continuation of the interfacial ﬁbrillation.
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characteristic DD-DF curves. Furthermore, we successfully
modeled the dynamic QCM-D response using the simple
Sauerbrey equation in the initial phase and an extended
Kelvin-Voigt model, including frequency-dependent terms,
in the late, more viscoelastic regimes. This modeling enabled
us to obtain a detailed quantitative description of the ﬁbrillo-
genesis process, with correlated changes in the surface mass
density and viscoelastic properties of the forming layer. In
phase I, we observe an initially rigid multilayer formation of
glucagon monomers with a subsequent slow rearrangement,
when possibly initial oligomers and other early species
within the ﬁbrillogenic hierarchy begin to form within the
interfacial layer. After a characteristic lag time, the onset of
ﬁbrillation and maturing of ﬁbrils passes a transition point,
when the layer becomes dramatically more viscoelastic, and
the ﬁbrillogenesis process enters phase II. This phase is
characterized by a decrease in shear modulus and shear vis-
cosity and a large increase in surface mass density. As illus-
trated in Fig. 7, we attribute this to the process of monomers
or oligomers being excluded from the layer as the ﬁbrils
mature, gradually forming a dense polymorphic network of
micrometer-long ﬁbrils growing from multiple nucleation
sites. In their continuous growth, these ﬁbrils form a still
more viscoelastic and elaborate network with increases in
both height and density of the layer. Finally, the process
progresses into a stable phase III as a result of the ﬁnite
amount of monomers available, effectively terminating the
interfacial ﬁbrillar formation. The process could be contin-
ued with a secondary injection of fresh monomers but, in-
terestingly, without a secondary lag time needed.
This work successfully demonstrates for the ﬁrst time the
ability to monitor in detail the temporal development and
viscoelastic changes accompanying multilayer amyloid de-
position at the solid-liquid interface in situ using QCM-D.
The robustness of the technique, consolidated by comple-
mentary AFM studies, should make it possible to combine a
large number of different components thought to be involved
in the plaque formation process and thus build up realistic
models of amyloid plaque formation in vitro as well as allow
further insight into biological interfacial deposition pro-
cesses in general.
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